Hepatic Medicine: Evidence and Research
Dr Pérez-López (Logout)

My Dovepress
About Dovepress

Open access peer-reviewed scientific and medical journals.
Open Access

Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Advocacy

Support Open Access and Dove Press
Reprints

Promotional Article Monitoring - further details
Favored Author Program

Real benefits for authors, including fast-track processing of papers.

Hepatic Medicine: Evidence and Research

Editor in Chief Gerond V. Lake-Bakaar, MD

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors
M Gabrovska, F Geurs, S Ponette, et al

A high prevalence of extreme hyperferritinemia in acute hepatitis patients
Kazuhiro Kotoh, Akihiro Ueda, Masatake Tanaka, et al.

Founding Author Papers
Submit your paper to one of these journals and the processing fee will be only EUR695, until further notice.
Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio

Favored Author Program

We offer real benefits to our authors, including fast-track processing of papers.
Award Nominations Open

Nominations are now open for International Journal of Nanomedicine (IJN) Early Career Scientist Award, International Journal of Nanomedicine (IJN) Distinguished Scientist Award
Call For Submissions

Submit Original Research Article, Review, Case Report, or Rapid Communication in Hepatic Medicine: Evidence and Research
About Dovepress

Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum